AstraZeneca Trixeo Wins EU Approval for Asthma Treatment
Cambridge, United Kingdom, September 23, 2026 AstraZeneca has announced that Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has received European Commission...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, United Kingdom, September 23, 2026 AstraZeneca has announced that Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has received European Commission...
PISCATAWAY, N.J., June 4, 2026 Kashiv BioSciences has announced a significant regulatory milestone with the validation and acceptance by...
